NDATRANSDERMALGEL
Approved
Jan 2009
Lifecycle
Peak
Competitive Pressure
0/100
Clinical Trials
3
Clinical Trials (3)
Oxybutynin Chloride in Managing Hot Flashes
Started Dec 2016
150 enrolled
Breast CarcinomaDuctal Breast Carcinoma In SituHot Flashes+2 more
An Efficacy and Safety Study of Oxybutynin Chloride Oral Osmotic Therapeutic System (OROS) in Korean Overactive Bladder Participants
Started Sep 2007
345 enrolled
Urinary Bladder, Overactive
The Effect of Extended-Release Oxybutynin Chloride on Vasomotor Symptoms in Healthy Post-Menopausal Women
Started Apr 2004
148 enrolled
MenopauseHot Flashes
Loss of Exclusivity
LOE Date
Mar 26, 2031
61 months away
Patent Expiry
Mar 26, 2031